CCL2 and neoplasm: A novel mechanism of radiotherapy resistance was recently discovered wherein PDAC cells respond to radiotherapy-induced stress by releasing high levels of CCL2 that recruit inflammatory monocytes to promote tumor proliferation and vascularity [19].